Back to
Franklin Templeton Inc.
AUPH
Showing 8 of 20 quarters
Position history for
Franklin Templeton Inc.'s holdings in Aurinia Pharmaceuticals Inc
Yes. Franklin Templeton holds 126,402 shares of AUPH (Aurinia Pharmaceuticals), worth $2.1M, as of its Q2 2026 13F filing. It reduced the position by 6,105 shares (-4.6%) from Q1 2026. Franklin Templeton has held AUPH since Q2 2023, across 13 quarterly 13F filings.
Current Value
$2.1M
Current Shares
126,402
Total Value Change
+$2M
Total Shares Change
+106,149
Quarter-by-Quarter History